An interactive decision-support tool, for you!

October the 1st

Cancer Rose - Press Release

October 1st, 2023

The French Association Cancer Rose proposes an interactive decision-support tool in three languages (French, English, German) on breast cancer screening to help each woman assess her own benefits/harms balance.

This tool can easily be used alone or with the help of a practitioner during a medical consultation.

The tool presents two versions for the balance of benefits and harms:  

  • A benefits/harms balance based on unfavorable hypotheses to screening.
  • A benefits/harms balance based on favorable hypotheses to screening.

It is possible to enter the age for the start and the end of participation in screening to obtain a personalized estimate of expected benefits (avoided deaths) and harms (overdiagnosis and false alarms) associated with screening.


Access to the decision tool possible too from the home page

Cancer Rose est un collectif de professionnels de la santé, rassemblés en association. Cancer Rose fonctionne sans publicité, sans conflit d’intérêt, sans subvention. Merci de soutenir notre action sur HelloAsso.

Cancer Rose is a French non-profit organization of health care professionals. Cancer Rose performs its activity without advertising, conflict of interest, subsidies. Thank you to support our activity on HelloAsso.